Summary
Perioperative chemotherapy provided benefit for patients with colorectal cancer who were treated with surgery for potentially resectable liver metastases. This article discusses the final Results of the EORTC Intergroup Randomized Phase 3 Study 40983 evaluating the benefit of perioperative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases.
- Gastrointestinal Cancers Clinical Trials
- © 2007 MD Conference Express
Tools
Final Results of the EORTC Intergroup Randomized Phase 3 Study 40983 Evaluating the Benefit of Perioperative FOLFOX4 Chemotherapy for Patients with Potentially Resectable Colorectal Cancer Liver Metastases
Permalink:
Table of contents
Cited By...
- No citing articles found.